Pandemic byline in Hospital & Healthcare

by LexaGene | May 3, 2018 | Biothreat Detection

Home » Biothreat Detection » Pandemic byline in Hospital & Healthcare

What would happen in the event of a deadly new strain of influenza? Dr. Jack Regan discusses the importance of open-access diagnostics in pandemic prevention.

Read the Full Article in Hospital & Healthcare Management

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Subscribe for Updates

Upcoming Events

No events in this category to show at this time.

See All Events

Latest Resources

MiQLab for Rapid Response to Novel Biothreats

Biothreat Detection

LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.

See All Resources